SMTL ID : 6b1h.1 (1 other biounit)

Crystal structure KPC-2 beta-lactamase complexed with WCK 4234 by co-crystallization

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.80 Å

Oligo State

monomer

Ligands

1 x C8Y: (2S,5R)-1-formyl-5-[(sulfooxy)amino]piperidine-2-carbonitrile(Covalent)

C8Y.1: 13 residues within 4Å: Chain A: C.47, S.48, K.51, W.83, S.108, N.110, L.145, N.148, T.194, K.212, T.213, G.214, T.215 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:W.83 Hydrogen bonds: A:S.48, A:S.108, A:S.108, A:N.110, A:N.148, A:T.194, A:T.213, A:T.213, A:T.213, A:T.213, A:T.215, A:T.215 Salt bridges: A:K.212

1 x SO4: SULFATE ION(Non-functional Binders)

SO4.2: 2 residues within 4Å: Chain A: P.72, T.93 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:T.93

1 x CL: CHLORIDE ION(Non-functional Binders)

CL.3: 2 residues within 4Å: Chain A: G.76, N.78 Ligand excluded by PLIP

1 x ACT: ACETATE ION(Non-functional Binders)

ACT.4: 9 residues within 4Å: Chain A: G.217, V.218, Y.219, G.220, T.221, K.247, D.249, K.250, H.251 6 PLIP interactions: 6 interactions with chain A Hydrogen bonds: A:G.220, A:T.221, A:H.251 Water bridges: A:V.218, A:V.218 Salt bridges: A:H.251

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Papp-Wallace, K.M. et al., Strategic Approaches to Overcome Resistance against Gram-Negative Pathogens Using beta-Lactamase Inhibitors and beta-Lactam Enhancers: Activity of Three Novel Diazabicyclooctanes WCK 5153, Zidebactam (WCK 5107), and WCK 4234. J. Med. Chem. (2018)

Release Date

2018-08-01

Peptides

Carbapenem-hydrolyzing beta-lactamase KPC: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Carbapenem-hydrolyzing beta-lactamase KPC

Related Entries With Identical Sequence